Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 36, Issue 10, Pages 7859-7863
Publisher
Springer Nature
Online
2015-05-06
DOI
10.1007/s13277-015-3506-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms
- (2015) X.-Q. Zhang et al. NEUROSCIENCE
- Pyramidal lobe decreases endogenous TSH stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer
- (2014) Nadia Sawicka-Gutaj et al. ANNALES D ENDOCRINOLOGIE
- Nicotinamide Phosphoribosyl Transferase/Pre-B Cell Colony-Enhancing Factor/Visfatin Is Required for Lymphocyte Development and Cellular Resistance to Genotoxic Stress
- (2014) A. Rongvaux et al. JOURNAL OF IMMUNOLOGY
- NAMPT-Mediated Salvage Synthesis of NAD+ Controls Morphofunctional Changes of Macrophages
- (2014) Gerda Venter et al. PLoS One
- Survivin Delta Ex3 Overexpression in Thyroid Malignancies
- (2014) Joanna Waligórska-Stachura et al. PLoS One
- Circulating levels of novel adipocytokines in patients with colorectal cancer
- (2013) Mohammad Sadegh Fazeli et al. CYTOKINE
- Completion thyroidectomy of well-differentiated thyroid cancer — a prospective, miserandomised study
- (2013) Monika Proczko et al. Endokrynologia Polska
- Visfatin, a potential biomarker and prognostic factor for endometrial cancer
- (2013) Wenyan Tian et al. GYNECOLOGIC ONCOLOGY
- Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice
- (2013) Rafaela da Silva et al. THROMBOSIS AND HAEMOSTASIS
- Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction
- (2012) Fabrizio Montecucco et al. ANTIOXIDANTS & REDOX SIGNALING
- Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells
- (2012) Basant Kumar Thakur et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, in Human Cancer Cells
- (2012) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Could serum visfatin be a potential biomarker for postmenopausal breast cancer?
- (2012) Maria Dalamaga et al. MATURITAS
- Nicotinamide phosphoribosyl-transferase/visfatin: A missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges
- (2012) Maria Dalamaga MEDICAL HYPOTHESES
- Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells
- (2012) Sarah C. Bowlby et al. PLoS One
- Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthrit
- (2011) Laura Evans et al. ARTHRITIS AND RHEUMATISM
- High Visfatin Expression in Breast Cancer Tissue Is Associated with Poor Survival
- (2011) Y.-C. Lee et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes
- (2011) Erik Schilling et al. Innate Immunity
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- CGB and GNRH1 expression analysis as a method of tumor cells metastatic spread detection in patients with gynecological malignances
- (2011) Mirosław Andrusiewicz et al. Journal of Translational Medicine
- Nampt/PBEF/visfatin and cancer
- (2010) Tie-qiang Bi et al. CANCER BIOLOGY & THERAPY
- Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer
- (2010) Takako Eguchi Nakajima et al. CANCER SCIENCE
- Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma
- (2010) H. Kato et al. CLINICAL CANCER RESEARCH
- Visfatin stimulates proliferation of MCF-7 human breast cancer cells
- (2010) Jae Geun Kim et al. MOLECULES AND CELLS
- Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
- (2009) Alexander R. Moschen et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
- (2008) J Nakano et al. BRITISH JOURNAL OF CANCER
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD
- (2008) Nathalie Busso et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More